Lidocaine

codes geen / geen

 

 

Formula

CAS

C14H22N2O

137-58-6

 
CAS: Chemical Abstract Service Registry Number
 

Background

Lidocaine is used as a local anesthetic and as an antiarhythmic agent.

 

Synonyms

Lidocaine
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-2´,6´-acetoxylidide
w-Diethylamino-2,6-dimethylacetanilide
Lignocaine
Xylocaine
Xylotox
Leostesin
EMLA® cream
Rucaina
Isicaine
Cuivasal
Duncaine
Sylestesin
Anestacon
Gravocain
Lidothesin
Xylocitin
Xylestesin

 

Uses

Anesthetic
Antiarrhythmic agent
EMLA® cream (lidocaine base + prilocaine base)

 

Cross-Reactions

Bupivacaine
Prilocaine
Cinchocaine
Mepivacaine

 

Unusual Reactions

 

 

References

1.

Turner, T.W., Contact dermatitis due to lignocaine. Contact Dermatitis, 1977. 3(4): p. 210-1.

2.

Fregert, S., E. Tegner, and I. Thelin, Contact allergy to lidocaine. Contact Dermatitis, 1979. 5(3): p. 185-8.

3.

Kernekamp, A.S. and W.G. Van Ketel, Contact allergy to lidocaine (Xylocaine, Lignocaine). Contact Dermatitis, 1979. 5(6): p. 403.

4.

Agathos, M., Anaphylactic reaction to framycetin (neomycin B) and lignocaine. Contact Dermatitis, 1980. 6(3): p. 236-7.

5.

Lahti, A., Non-immunologic contact urticaria. Acta Dermato-Venereologica. Supplementum, 1980. Suppl(91): p. 1-49.

6.

Nurse, D.S. and S.A. Rosner, Contact dermatitis due to lignocaine. Contact Dermatitis, 1983. 9(6): p. 513.

7.

Fernandes de Corres, L. and I. Leanizbarrutia, Dermatitis from lignocaine. Contact Dermatitis, 1985. 12(2): p. 114-5.

8.

Curley, R.K., A.W. Macfarlane, and C.M. King, Contact sensitivity to the amide anesthetics lidocaine, prilocaine, and mepivacaine. Case report and review of the literature. Archives of Dermatology, 1986. 122(8): p. 924-6.

9.

Black, R.J., T.A. Dawson, and W.C. Strang, Contact sensitivity to lignocaine and prilocaine. Contact Dermatitis, 1990. 23(2): p. 117-8.

10.

Klein, C.E. and H. Gall, Type IV allergy to amide-type local anesthetics. Contact Dermatitis, 1991. 25(1): p. 45-8.

11.

Duggan, M., et al., Reaction to topical lignocaine in a patient with contact dermatitis. Contact Dermatitis, 1993. 28(3): p. 190-1.

12.

Hardwick, N. and C.M. King, Contact allergy to lignocaine with cross-reaction to bupivacaine. Contact Dermatitis, 1994. 30(4): p. 245-6.

 

 

 

 

 

Omhoog21-07-2011 (JRM) -  www.huidziekten.nl